抗人CD64抗体（克隆号H22）引用文献

抗人CD64单克隆抗体（克隆号H22）引用文献如下：

1. An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy
2. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody: A potential strategy to enhance anti-TNF therapy
3. CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo
4.Human CD64-targeted non-viral siRNA delivery system for blood monocyte gene modulation
5.Design, optimization, production and activity testing of recombinant immunotoxins expressed in plants and plant cells for the treatment of monocytic leukemia
6.Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies
7.Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcγRI × anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer
8.Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8+ T cell activity and Fcγ receptor-mediated modulation of the tumor microenvironment
9.Targeting CD39 in cancer reveals an extracellular ATP and inflammasome driven tumor immunity
10.Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice
……

Syd Labs抗人CD64重组抗体（克隆号H22）：

Syd Labs 重组抗人CD64单克隆抗体，小鼠IgG1 Kappa，体内实验级(克隆号H22)（In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Mouse IgG1 Kappa (Clone: H22)，货号：PA007393.m1）是用哺乳动物细胞生产的重组抗体，可用于流式细胞术、免疫组织化学（IHC）和免疫沉淀（IP）等研究。

如果需要了解更多有关Syd Labs 重组抗人CD64单抗(克隆号H22)信息，比如Syd Labs 抗人CD64单抗使用说明等资料，欢迎联系多找找获取。

特此声明：多找找推广的所有产品和服务的价格、货期和规格等信息如有更改，恕不另行通知。除非另有说明，多找找推广的所有目录和定制产品仅限于科研使用，不得用于人类或动物的诊断或治疗。